Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-02-20 @ 3:47 PM
Study NCT ID:
NCT02762266
Status:
TERMINATED
Last Update Posted:
2024-03-12
First Post:
2016-04-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Sponsor:
Stanford University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-05
First Submit QC Date:
None
Study First Post Date:
2016-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-12-12
Results First Submit QC Date:
None
Results First Post Date:
2024-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-08
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL